Creative Medical Tech Holdings Files Definitive Proxy Statement
Ticker: CELZ · Form: DEF 14A · Filed: Mar 17, 2025 · CIK: 1187953
Sentiment: neutral
Topics: proxy-statement, disclosure, governance
TL;DR
CMED filed its DEF 14A proxy statement. Standard disclosure.
AI Summary
Creative Medical Technology Holdings, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 17, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as Jolley Marketing Inc. until September 10, 2002, is based in Phoenix, Arizona, and operates in the Biological Products sector. This filing is a standard disclosure related to shareholder matters.
Why It Matters
This filing provides shareholders with essential information regarding company governance and upcoming shareholder meetings, impacting their voting rights and understanding of corporate decisions.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing, which is a standard disclosure document for public companies and does not inherently present new risks.
Key Players & Entities
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (company) — Registrant
- JOLLEY MARKETING INC (company) — Former company name
- 20250317 (date) — Filing date
- 20250319 (date) — Period of report
- 0001187953 (company) — Central Index Key
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used by companies to solicit proxies from shareholders for an upcoming shareholder meeting, providing details on matters to be voted upon.
When was Creative Medical Technology Holdings, Inc. formerly known as Jolley Marketing Inc.?
Creative Medical Technology Holdings, Inc. was formerly known as Jolley Marketing Inc. until September 10, 2002.
What is the business address of Creative Medical Technology Holdings, Inc.?
The business address of Creative Medical Technology Holdings, Inc. is 211 E. Osborn Rd., Phoenix, AZ 85012.
What is the SIC code for Creative Medical Technology Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Creative Medical Technology Holdings, Inc. is 2836, which corresponds to Biological Products (no diagnostic substances).
On what date was this Definitive Proxy Statement filed?
This Definitive Proxy Statement was filed on March 17, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 17, 2025 regarding CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ).